Abstract
Bladder cancer is more frequent in the spinal cordinjured population. The current literature concerning this subject is reviewed below; the incidence, pathology, diagnosis, and prognosis are discussed, along with some specific considerations regarding the treatment of bladder cancers in patients with spinal cord disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bejany DE, Lockhart JL, Rhany RK (1987) Malignant vesical tumors following spinal cord injury. J Urol 138: 1390–1392
Bickel A, Culkin DJ, Wheeler JS Jr (1991) Bladder cancer in spinal cord injury patients. J Urol 146: 1240–1242
Binard JE, Persky L, Lockhart JL (1996) Intermittent catheterisation the right way (volume versus time directed). J Spin Cord Med 19: 194–196
Broecker BH, Klein FA, Hackler RH (1981) Cancer of the bladder in spinal cord injury. J Urol 125: 196–197
Cannon J, Linke CA, Cos LR (1991) Cyclophosphamide associated carcinoma of urothelium. Modalities for prevention. Urology 38: 413–416
Chao R, Clowers D, Mayo ME (1993) Fate of the upper urinary tracts in patients with indwelling catheters after spinal cord injury. Urology 42: 259–262
Cutler SJ, Heney NM, Friedell GH (1982) Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In: Bonney WW, Prout GR (eds) Bladder cancer, AUA Monographs. Williams and Wilkins, Baltimore
De Ridder D, Van Poppel H, Baert L (1996a) From time dependent intermittent catheterisation to volume dependent catheterisation in multiple sclerosis patients, using the PCI5000. Spinal Cord (in press)
De Ridder D, Van Poppel H, Baert L (1996b) Intravesical capsaicin as treatment for detrusor hyperreflexia in multiple sclerosis: results in 41 patients. Neurourol Urodyn 15: 376–377
De Ridder D, Van Poppet H, Demonty R, Baert L (1997) Cancer of the bladder in multiple sclerosis patients treated with cyclophosphamide. Submitted to the J Urol
D’Hallewin MA, Baert L (1996) Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 155: 475–476
D’Hallewin MA, Baert L, Vanherzeele H (1994) In vivo fluorescence detection of human bladder carcinoma without sensitizing agent. J Am Paraplegia Soc 17: 161–164
Djavan B, Litwiller SC, Milchgrub S (1995) Mucinous adenocarcinoma in defunctionalized bladders. Urology 46: 107–110
El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH (1981) The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer 48: 2643
El-Masri WS, Fellows G (1981) Bladder cancer after spinal cord injury. Paraplegia 19: 265–270
Estève J, Kricker A, Ferlay J, Parkin DM (1993) Facts and figures of cancer in the European Community. International Agency for Research on Cancer, Lyon, p 36, p 50
Faysal MH, Frieha FS (1981) Primary neoplasm in vesical diverticula: a report of 12 cases. Br J Urol 53: 141
Jacobs SC, Kaufman JM (1978) Complications of permanent bladder catheter drainage in spinal cord injury patients. J Urol 119: 740–741
Kaldor JM, Day NE, Kittelmann B, et al. (1995) Bladder tumors following chemotherapy and radiotherapy for ovarian cancer: a case control study. Int J Cancer 63: 1–6
Kantor AF, Hartge P, Hoover RN, et al. (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119: 510–515
Kaufman JM, Fam B, Jacobs SC, et al. (1977) Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 118: 967–971
Kornhuber HH, Petru E, Schmähl D (1987) Zum Malignitätsrisiko bei Cyclophosphamid Therapie der Multiplen Sklerose. DMW 112: 530
Laterre C, Sindic CJM, Heule H (1989) Oral cyclophosphamide treatment in multiple sclerosis. In: Gonsette R, Delmotte P (ed) Recent advances in multiple sclerosis therapy. Elsevier, Amsterdam, pp 147–150
Levine LA, Richic JP (1989) Urological complications of cyclophosphamide. J Urol 141: 1063–1069
Lin JI, Tseng CH, Choy C, et al. (1980) Diffuse cystitis glandularis associated with adenocarcinomatous change. Urology 15: 411–415
Locke JR, Hill DE, Walzer Y (1985) Incidence of squamous cell carcinoma in patients with long term catheter drainage. J Urol 133: 1034–1035
Malek RS, Rosen JS, O’Dea MJ (1983) Adenocarcinoma of bladder. Urology 21: 357
Melzak J (1966) The incidence of bladder cancer in paraplegia. Paraplegia 4: 85–96
Micic S, Ilic V (1983) Incidence of neoplasm in vesical diverticula. J Urol 129: 734
Moloney PJ, Fenster HN, McLoughlin MC (1981) Carcinoma in the defunctionalized tract. J Urol 126: 260
Mostofi FK (1954) Potentialities of bladder epithelium. J Urol 71: 705
Ortiz A, Gonzalez-Parra E, Alvarez-Costa G, Egido J (1992) Bladder cancer after cyclophosphamide therapy for lupus nephritis. Nephron 60: 378–379
Radis CD, Kahl LE, Baker GL, et al. (1995) Effects of cyclophosphamide on the development of malignancy and on long term survival of patients with rheumatoid arthritis: a 20 year follow up. Arthritis Rheum 38: 1120–1127
Robertson DAF, Low-Beer TS (1983) Long term consequences of arsenical treatment for multiple sclerosis. BMJ 286: 605–606
Selzman AA, Hampel N (1993) Urological complications of spinal cord injury. Urol Clin North Am 20: 453–464
Sene AP, Massey JA, McMahon RTF, et al. (1990) Squamous cell carcinoma in a patient on clean intermittent self catheterisation. Br J Urol 65: 213
Stein JP, Skinner EC, Boyd SD, Skinner DG (1993) Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener’s granulomatosis: a report of 2 cases. J Urol 149: 588–589
Stonehill WH, Dmochowski RR, Patterson AL, Cox CE (1996) Risk factors for bladder tumors in spinal cord injury patients. J Urol 155: 1248–1250
Sweeney P, Kursh ED, MI Resnick (1992) Partial cystectomy. Urol Clin North Am 19: 707–708
Travis LB, Curtis RE, Glinelius B, et al. (1995) Bladder and kidney cancer following cyclophosphamide therapy for non Hodgkin lymphoma. J Natl Cancer Inst 87: 524–530
Tuttle TM, Williams GM, Marshall FF (1988) Evidence of cyclophosphamide induced transitional cell carcinoma in a renal transplant patient. J Urol 140: 1009–1011
Van Poppel H, Stessens R, De Vos R, Van Damme B (1986) Isolated condyloma acuminatum of the bladder in a patient with multiple sclerosis: etiological and pathological considerations. J Urol 136: 1071–1073
Wiedemann A, Diekmann WP, Holtmann G, Kracht H (1995) Report of a case with giant condyloma ( BuschkeLöwenstein tumor) localized in the bladder. J Urol 153: 1222–1224
Yaqoob M, McClelland P, Bell GM, et al. (1991) Bladder tumors in paraplegic patients on renal replacement therapy. Lancet 338: 1554–1555
Young RH, Parkhust EC (1984) Mucinous adenocarcinoma of bladder. Urology 24: 192–195
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
De Ridder, D.J.M.K., Binard, J.E., Baert, L. (1998). Special Considerations in the Management of Carcinoma in the Neurogenic Bladder. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Bladder. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60258-0_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-60258-0_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64323-1
Online ISBN: 978-3-642-60258-0
eBook Packages: Springer Book Archive